Targeting Nodal in malignant melanoma cells
- 20 March 2007
- journal article
- review article
- Published by Taylor & Francis in Emerging Therapeutic Targets
- Vol. 11 (4), 497-505
- https://doi.org/10.1517/14728222.11.4.497
Abstract
(2007). Targeting Nodal in malignant melanoma cells. Expert Opinion on Therapeutic Targets: Vol. 11, No. 4, pp. 497-505. doi: 10.1517/14728222.11.4.497Keywords
This publication has 50 references indexed in Scilit:
- Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon CancerClinical Cancer Research, 2006
- Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressivenessNature Medicine, 2006
- Inhibition of TGFβ signaling in cancer therapyCurrent Opinion in Genetics & Development, 2005
- A Tumorigenic Subpopulation with Stem Cell Properties in MelanomasCancer Research, 2005
- Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cellsJournal of Cell Science, 2005
- TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cellsDevelopment, 2005
- The genetics of malignant melanoma: lessons from mouse and manNature Reviews Cancer, 2003
- Molecular signature of human embryonic stem cells and its comparison with the mouseDevelopmental Biology, 2003
- Cripto-1 Activates Nodal- and ALK4-Dependent and -Independent Signaling Pathways in Mammary Epithelial CellsMolecular and Cellular Biology, 2002
- Coexpression of Vimentin and Keratins by Human Melanoma Tumor Cells: Correlation With Invasive and Metastatic PotentialJNCI Journal of the National Cancer Institute, 1992